Nonclinical investigation of the potential of MHAA4549A, an anti-influenza A therapeutic antibody, to mediate antibody-dependent enhancement. [PDF]
Rao GK +12 more
europepmc +1 more source
Post-acute symptom persistence following SARS-CoV-2, RSV, and influenza in children: A retrospective cohort study. [PDF]
Bedir F, Demir V.
europepmc +1 more source
Does acute inflammation triggered by infection promote cancer progression? [PDF]
Valença-Pereira F +3 more
europepmc +1 more source
Endogenous Expression of an RNA-Hydrolyzing Minibody Enhances the Therapeutic Effects Against Influenza a Virus Compared to Therapeutically Intranasal Administration. [PDF]
Luong QXT +9 more
europepmc +1 more source
No Evidence of HPAI H5N1 in Coastal Areas of Australia's Antarctic Territory During the 2025/26 Austral Summer. [PDF]
Emmerson L +6 more
europepmc +1 more source
ATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication. [PDF]
Lu Y +22 more
europepmc +1 more source
Pulmonarom<sup>®</sup> promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. [PDF]
Solano-Gálvez SG +12 more
europepmc +1 more source
Characteristics and outcomes of adult patients hospitalised with RSV infection, influenza or COVID-19 in Belgium, winter seasons 2023/24 and 2024/25. [PDF]
Lafort Y +14 more
europepmc +1 more source

